| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |